ALA-4000, Long-acting Injectable of Apomorphine for Parkinson's Disease and Dyskinesia

Name: ALA-4000, Long-acting Injectable of Apomorphine for Parkinson's Disease and Dyskinesia
Availability: ala-4000-long-acting-injectable-of-apomo-277383.html

Category:Finished Dosage > Nervous System Preparations
Product Name:ALA-4000, Long-acting Injectable of Apomorphine for Parkinson's Disease and Dyskinesia
CAS No.:NA
Standard:In-house Standards
Price(USD):Negotiable
Company:Alar Pharmaceuticals Inc.

Send Inquiry

Favorites

Similar Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Basic Info

Grade: pharmaceutical grade, injection grade

Factory Location: Taiwan

Main Sales Markets: North America,Western Europe,Australasia,Asia
Sample Provided: no

Payment Terms: L/C

ALA-4000 is designed as an Apomorphine sustained-release injection lasting at least one week for treating Parkinson's Disease. The candidate formulations are screened through in vitro dissolution tests and pharmacokinetic studies in SD rats and minipigs.

Send your message to this supplier

From:
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

ALA-4000, Long-acting Injectable of Apomorphine for Parkinson's Disease and Dyskinesia

You may like